celgene corp (CELG:NASDAQ GS)
Thomas O. Daniel M.D.
President of Research & Early Development and Executive Vice President, Celgene Corporation
|Age||Total Calculated Compensation||This person is connected to 27 board members in 2 different organizations across 6 different industries.|
See Board Relationships
As of Fiscal Year 2013
Dr. Thomas O. Daniel, M.D., has been the President of Research & Early development of Celgene Corporation since December 2006 and also served as its Executive Vice President since February 15, 2012. Dr. Daniel has more than two decades of medical and pharmaceutical research experience and served as the Chief Scientific Officer at Ambrx Inc. since September 2003. He served as the Vice President of Research at Amgen Inc., where he served as Research Site Head of Amgen ...
86 Morris AvenuePhone: 908-673-9000
Summit, New Jersey 07901
Board Members Memberships*
University of Texas Southwestern Medical Center - Dallas
|Robert A. Bradway||Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee|
|Lamberto Andreotti||Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee|
Bristol-Myers Squibb Company
|Leonard S. Schleifer M.D., Ph.D.||Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee|
Regeneron Pharmaceuticals, Inc.
|Yoshihiko Hatanaka||Chief Executive Officer, President and Representative Director|
Astellas Pharma, Inc.
|Richard A. Gonzalez||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|$1.5M||Compensation as of Fiscal Year 2013.|